Role of 5-HT2A receptors in the effects of ayahuasca on ethanol self-administration using a two-bottle choice paradigm in male mice

Rationale Ayahuasca has been proposed as a potential treatment of alcohol (ethanol) use disorder (AUD). The serotonin 5-HT 2A receptor agonist N,N-dimethyltryptamine (DMT) is the main psychoactive component of ayahuasca, suggesting that its therapeutic effects may be mediated by 5-HT 2A receptors. O...

Full description

Saved in:
Bibliographic Details
Published inPsychopharmacology Vol. 239; no. 6; pp. 1679 - 1687
Main Authors Serra, Yasmim A., Barros-Santos, Thaísa, Anjos-Santos, Alexia, Kisaki, Natali D., Jovita-Farias, Caio, Leite, João P. C., Santana, Maria C. E., Coimbra, João P. S. A., de Jesus, Nailton M. S., Sulima, Agnieszka, Barbosa, Paulo C. R., Malpezzi-Marinho, Elena L. A., Rice, Kenner C., Oliveira-Lima, Alexandre J., Berro, Laís F., Marinho, Eduardo A. V.
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.06.2022
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Rationale Ayahuasca has been proposed as a potential treatment of alcohol (ethanol) use disorder (AUD). The serotonin 5-HT 2A receptor agonist N,N-dimethyltryptamine (DMT) is the main psychoactive component of ayahuasca, suggesting that its therapeutic effects may be mediated by 5-HT 2A receptors. Objectives The aim of the present study was to investigate the effects of ayahuasca on the expression of ethanol self-administration using a two-bottle choice procedure and the role of 5-HT 2A receptors in those effects. Methods Male mice had intermittent access to ethanol (10% v/v) in a two-bottle choice procedure for 30 days. Animals were then submitted to 3 treatment phases, each followed by ethanol re-exposure tests. During the treatment phase, every 3 days, animals received i.p. injections of either vehicle or the 5-HT 2A receptor antagonist M100907 (M100, 1 mg/kg) followed by an i.g. (gavage) administration of vehicle or ayahuasca (100 mg/kg) and were exposed to the self-administration apparatus with no ethanol availability. During re-exposure tests, animals were submitted to the same conditions as during acquisition, with no treatments prior to those sessions. Results Treatment with ayahuasca blocked the expression of ethanol self-administration, decreasing ethanol intake and preference during re-exposure tests. Pretreatment with M100 blocked the effects of ayahuasca on ethanol drinking without significantly attenuating ethanol self-administration. Conclusions Treatment with ayahuasca during alcohol abstinence blocked the expression of alcohol self-administration in mice, and 5-HT 2A receptor activation is critical for those effects to emerge. Our findings support a potential for ayahuasca and other 5-HT 2A receptor agonists as adjunctive pharmacotherapies for the treatment of AUD.
AbstractList Abstract RationaleAyahuasca has been proposed as a potential treatment of alcohol (ethanol) use disorder (AUD). The serotonin 5-HT2A receptor agonist N,N-dimethyltryptamine (DMT) is the main psychoactive component of ayahuasca, suggesting that its therapeutic effects may be mediated by 5-HT2A receptors.ObjectivesThe aim of the present study was to investigate the effects of ayahuasca on the expression of ethanol self-administration using a two-bottle choice procedure and the role of 5-HT2A receptors in those effects.MethodsMale mice had intermittent access to ethanol (10% v/v) in a two-bottle choice procedure for 30 days. Animals were then submitted to 3 treatment phases, each followed by ethanol re-exposure tests. During the treatment phase, every 3 days, animals received i.p. injections of either vehicle or the 5-HT2A receptor antagonist M100907 (M100, 1 mg/kg) followed by an i.g. (gavage) administration of vehicle or ayahuasca (100 mg/kg) and were exposed to the self-administration apparatus with no ethanol availability. During re-exposure tests, animals were submitted to the same conditions as during acquisition, with no treatments prior to those sessions.ResultsTreatment with ayahuasca blocked the expression of ethanol self-administration, decreasing ethanol intake and preference during re-exposure tests. Pretreatment with M100 blocked the effects of ayahuasca on ethanol drinking without significantly attenuating ethanol self-administration.ConclusionsTreatment with ayahuasca during alcohol abstinence blocked the expression of alcohol self-administration in mice, and 5-HT2A receptor activation is critical for those effects to emerge. Our findings support a potential for ayahuasca and other 5-HT2A receptor agonists as adjunctive pharmacotherapies for the treatment of AUD.
Rationale Ayahuasca has been proposed as a potential treatment of alcohol (ethanol) use disorder (AUD). The serotonin 5-HT 2A receptor agonist N,N-dimethyltryptamine (DMT) is the main psychoactive component of ayahuasca, suggesting that its therapeutic effects may be mediated by 5-HT 2A receptors. Objectives The aim of the present study was to investigate the effects of ayahuasca on the expression of ethanol self-administration using a two-bottle choice procedure and the role of 5-HT 2A receptors in those effects. Methods Male mice had intermittent access to ethanol (10% v/v) in a two-bottle choice procedure for 30 days. Animals were then submitted to 3 treatment phases, each followed by ethanol re-exposure tests. During the treatment phase, every 3 days, animals received i.p. injections of either vehicle or the 5-HT 2A receptor antagonist M100907 (M100, 1 mg/kg) followed by an i.g. (gavage) administration of vehicle or ayahuasca (100 mg/kg) and were exposed to the self-administration apparatus with no ethanol availability. During re-exposure tests, animals were submitted to the same conditions as during acquisition, with no treatments prior to those sessions. Results Treatment with ayahuasca blocked the expression of ethanol self-administration, decreasing ethanol intake and preference during re-exposure tests. Pretreatment with M100 blocked the effects of ayahuasca on ethanol drinking without significantly attenuating ethanol self-administration. Conclusions Treatment with ayahuasca during alcohol abstinence blocked the expression of alcohol self-administration in mice, and 5-HT 2A receptor activation is critical for those effects to emerge. Our findings support a potential for ayahuasca and other 5-HT 2A receptor agonists as adjunctive pharmacotherapies for the treatment of AUD.
RATIONALEAyahuasca has been proposed as a potential treatment of alcohol (ethanol) use disorder (AUD). The serotonin 5-HT2A receptor agonist N,N-dimethyltryptamine (DMT) is the main psychoactive component of ayahuasca, suggesting that its therapeutic effects may be mediated by 5-HT2A receptors.OBJECTIVESThe aim of the present study was to investigate the effects of ayahuasca on the expression of ethanol self-administration using a two-bottle choice procedure and the role of 5-HT2A receptors in those effects.METHODSMale mice had intermittent access to ethanol (10% v/v) in a two-bottle choice procedure for 30 days. Animals were then submitted to 3 treatment phases, each followed by ethanol re-exposure tests. During the treatment phase, every 3 days, animals received i.p. injections of either vehicle or the 5-HT2A receptor antagonist M100907 (M100, 1 mg/kg) followed by an i.g. (gavage) administration of vehicle or ayahuasca (100 mg/kg) and were exposed to the self-administration apparatus with no ethanol availability. During re-exposure tests, animals were submitted to the same conditions as during acquisition, with no treatments prior to those sessions.RESULTSTreatment with ayahuasca blocked the expression of ethanol self-administration, decreasing ethanol intake and preference during re-exposure tests. Pretreatment with M100 blocked the effects of ayahuasca on ethanol drinking without significantly attenuating ethanol self-administration.CONCLUSIONSTreatment with ayahuasca during alcohol abstinence blocked the expression of alcohol self-administration in mice, and 5-HT2A receptor activation is critical for those effects to emerge. Our findings support a potential for ayahuasca and other 5-HT2A receptor agonists as adjunctive pharmacotherapies for the treatment of AUD.
Author Barros-Santos, Thaísa
Barbosa, Paulo C. R.
Marinho, Eduardo A. V.
de Jesus, Nailton M. S.
Serra, Yasmim A.
Coimbra, João P. S. A.
Santana, Maria C. E.
Sulima, Agnieszka
Malpezzi-Marinho, Elena L. A.
Rice, Kenner C.
Jovita-Farias, Caio
Oliveira-Lima, Alexandre J.
Leite, João P. C.
Anjos-Santos, Alexia
Kisaki, Natali D.
Berro, Laís F.
AuthorAffiliation 1 Department of Health Sciences, Universidade Estadual de Santa Cruz, Ilhéus, BA, Brazil
2 Department of Biological Sciences, Universidade Estadual de Santa Cruz, Ilhéus, BA, Brazil
4 Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, 2500 N State St, Jackson, MS 39216, USA
3 Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA
AuthorAffiliation_xml – name: 4 Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, 2500 N State St, Jackson, MS 39216, USA
– name: 1 Department of Health Sciences, Universidade Estadual de Santa Cruz, Ilhéus, BA, Brazil
– name: 2 Department of Biological Sciences, Universidade Estadual de Santa Cruz, Ilhéus, BA, Brazil
– name: 3 Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, USA
Author_xml – sequence: 1
  givenname: Yasmim A.
  surname: Serra
  fullname: Serra, Yasmim A.
  organization: Department of Health Sciences, Universidade Estadual de Santa Cruz
– sequence: 2
  givenname: Thaísa
  surname: Barros-Santos
  fullname: Barros-Santos, Thaísa
  organization: Department of Biological Sciences, Universidade Estadual de Santa Cruz
– sequence: 3
  givenname: Alexia
  surname: Anjos-Santos
  fullname: Anjos-Santos, Alexia
  organization: Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, National Institute On Drug Abuse and the National Institute On Alcohol Abuse and Alcoholism
– sequence: 4
  givenname: Natali D.
  surname: Kisaki
  fullname: Kisaki, Natali D.
  organization: Department of Health Sciences, Universidade Estadual de Santa Cruz
– sequence: 5
  givenname: Caio
  surname: Jovita-Farias
  fullname: Jovita-Farias, Caio
  organization: Department of Health Sciences, Universidade Estadual de Santa Cruz
– sequence: 6
  givenname: João P. C.
  surname: Leite
  fullname: Leite, João P. C.
  organization: Department of Biological Sciences, Universidade Estadual de Santa Cruz
– sequence: 7
  givenname: Maria C. E.
  surname: Santana
  fullname: Santana, Maria C. E.
  organization: Department of Biological Sciences, Universidade Estadual de Santa Cruz
– sequence: 8
  givenname: João P. S. A.
  surname: Coimbra
  fullname: Coimbra, João P. S. A.
  organization: Department of Biological Sciences, Universidade Estadual de Santa Cruz
– sequence: 9
  givenname: Nailton M. S.
  surname: de Jesus
  fullname: de Jesus, Nailton M. S.
  organization: Department of Biological Sciences, Universidade Estadual de Santa Cruz
– sequence: 10
  givenname: Agnieszka
  surname: Sulima
  fullname: Sulima, Agnieszka
  organization: Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, National Institute On Drug Abuse and the National Institute On Alcohol Abuse and Alcoholism
– sequence: 11
  givenname: Paulo C. R.
  surname: Barbosa
  fullname: Barbosa, Paulo C. R.
  organization: Department of Health Sciences, Universidade Estadual de Santa Cruz
– sequence: 12
  givenname: Elena L. A.
  surname: Malpezzi-Marinho
  fullname: Malpezzi-Marinho, Elena L. A.
  organization: Department of Biological Sciences, Universidade Estadual de Santa Cruz
– sequence: 13
  givenname: Kenner C.
  surname: Rice
  fullname: Rice, Kenner C.
  organization: Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, National Institute On Drug Abuse and the National Institute On Alcohol Abuse and Alcoholism
– sequence: 14
  givenname: Alexandre J.
  surname: Oliveira-Lima
  fullname: Oliveira-Lima, Alexandre J.
  organization: Department of Health Sciences, Universidade Estadual de Santa Cruz
– sequence: 15
  givenname: Laís F.
  orcidid: 0000-0003-4841-4117
  surname: Berro
  fullname: Berro, Laís F.
  email: lberro@umc.edu
  organization: Department of Health Sciences, Universidade Estadual de Santa Cruz, Department of Psychiatry and Human Behavior, Center for Innovation and Discovery in Addictions, University of Mississippi Medical Center
– sequence: 16
  givenname: Eduardo A. V.
  surname: Marinho
  fullname: Marinho, Eduardo A. V.
  email: eavmarinho@uesc.br
  organization: Department of Health Sciences, Universidade Estadual de Santa Cruz
BookMark eNp9kU9v1DAQxS1URLeFL8DJEhcuhvGfJM4JVRVQpEpIqJwtrzPZuErsxXZY9cwXx8tWIDjgi-V5v3kz1rsgZyEGJOQlhzccoHubAQSXDIRg0HJQ7PCEbLiSggnoxBnZAEjJJG_0ObnI-R7qUVo9I-eyEY2Ett-QH1_ijDSOtGE3d-KKJnS4LzFl6gMtE1IcR3QlHxH7YKfVZmdpDBTLZEOcacZ5ZHZYfPC5JFt81dbsw45aWg6RbWMpdYKbondI9zbZwe-Wo_tia32p1efk6WjnjC8e70vy9cP7u-sbdvv546frq1vmFOjC2rYZdSeElV2PWxzF8cW3YpBSK6mkdY1rR664rjoX3YCt662CUaMeehjkJXl38t2v2wUHh6EuPJt98otNDyZab_5Wgp_MLn43HLoGlJDV4fWjQ4rfVszFLD47nGcbMK7ZiFa2uu0VqIq--ge9j2sK9X-V6oSWfd93lRInyqWYc8Lx9zYczDFkcwrZ1JDNr5DNoTbJU1OucNhh-mP9n66fNpCrew
CitedBy_id crossref_primary_10_3390_plants12132573
crossref_primary_10_1007_s00213_023_06460_1
crossref_primary_10_1038_s41386_023_01666_5
crossref_primary_10_1016_j_ynstr_2024_100618
crossref_primary_10_3389_fphar_2022_1074633
crossref_primary_10_1007_s00702_024_02757_3
crossref_primary_10_1007_s00213_022_06152_2
crossref_primary_10_1016_j_pnpbp_2023_110738
crossref_primary_10_1021_acschemneuro_2c00718
crossref_primary_10_3390_psychoactives3010007
crossref_primary_10_1097_JCP_0000000000001872
crossref_primary_10_1007_s40429_024_00581_z
crossref_primary_10_3390_ijms24021329
Cites_doi 10.1177/0269881114565144
10.1124/pr.114.009514
10.1097/FBP.0000000000000628
10.1016/S0014-2999(99)00125-9
10.1007/s00213-009-1468-9
10.2174/15733998113099990003
10.1016/j.comppsych.2016.09.003
10.3389/fphar.2018.00561
10.2174/15733998113099990002
10.1126/sciadv.aax4043
10.1016/S0376-8716(99)00148-9
10.1016/j.pharmthera.2004.03.002
10.1001/jamapsychiatry.2015.0584
10.1016/j.alcohol.2019.10.005
10.3389/fpsyt.2018.00136
10.2174/1570159X16666180125095902
10.1080/02791072.2013.873157
10.1111/dar.12985
10.1007/s00213-020-05609-6
10.1111/j.1530-0277.2010.01261.x
10.1021/cn300072u
10.1016/j.beproc.2017.04.019
10.1111/j.1360-0443.2012.04054.x
10.1037/a0014592
10.1111/dar.13348
10.1016/j.physbeh.2015.01.032
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022
The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022.
Copyright_xml – notice: The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022
– notice: The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022.
DBID AAYXX
CITATION
3V.
7QG
7QR
7RV
7TK
7X7
7XB
88E
88G
8AO
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
K9.
KB0
M0S
M1P
M2M
NAPCQ
P64
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
DOI 10.1007/s00213-022-06104-w
DatabaseName CrossRef
ProQuest Central (Corporate)
Animal Behavior Abstracts
Chemoreception Abstracts
ProQuest Nursing and Allied Health Journals
Neurosciences Abstracts
Health & Medical Collection (Proquest)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
ProQuest Pharma Collection
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
AUTh Library subscriptions: ProQuest Central
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Psychology Database (ProQuest)
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
ProQuest One Psychology
ProQuest Central Student
Technology Research Database
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Chemoreception Abstracts
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
Animal Behavior Abstracts
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest One Psychology

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: BENPR
  name: AUTh Library subscriptions: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1432-2072
EndPage 1687
ExternalDocumentID 10_1007_s00213_022_06104_w
GrantInformation_xml – fundername: National Institute on Drug Abuse
  funderid: http://dx.doi.org/10.13039/100000026
– fundername: Conselho Nacional de Desenvolvimento Científico e Tecnológico
  funderid: http://dx.doi.org/10.13039/501100003593
– fundername: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  funderid: http://dx.doi.org/10.13039/501100002322
– fundername: Fundação de Amparo à Pesquisa do Estado da Bahia
  funderid: http://dx.doi.org/10.13039/501100006181
– fundername: National Institute on Alcohol Abuse and Alcoholism
  funderid: http://dx.doi.org/10.13039/100000027
GroupedDBID -4W
-BR
.55
3SX
40D
40E
95.
95~
ABMNI
AGWIL
ALMA_UNASSIGNED_HOLDINGS
KOW
N2Q
R9-
RHV
SBY
SOJ
X7M
~EX
AAYXX
CITATION
3V.
7QG
7QR
7RV
7TK
7X7
7XB
88E
8AO
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FR3
FYUFA
GNUQQ
K9.
M1P
M2M
NAPCQ
P64
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
---
-56
-5G
-EM
-~C
.86
.VR
04C
06C
06D
0R~
0VY
123
199
1N0
203
29P
29~
2J2
2JN
2JY
2KG
2KM
2LR
2QV
2~H
30V
36B
4.4
406
408
409
5RE
5VS
67N
67Z
6NX
78A
7X8
8TC
8UJ
95-
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANZL
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYZH
ABAKF
ABBBX
ABBXA
ABDBF
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABIVO
ABJNI
ABJOX
ABKCH
ABKTR
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABWNU
ABXPI
ACAOD
ACDTI
ACGFS
ACHSB
ACHXU
ACIWK
ACKNC
ACMDZ
ACMLO
ACNCT
ACOKC
ACOMO
ACPRK
ACZOJ
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFLOW
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGMZJ
AGQEE
AGQMX
AGRTI
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJRNO
AJZVZ
AKMHD
ALIPV
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
B0M
BA0
BGNMA
BKEYQ
BMSDO
BPHCQ
BVXVI
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
DXH
EAD
EAP
EBC
EBD
EBLON
EBS
EIHBH
EIOEI
EMB
EMK
EMOBN
EPAXT
EPL
EPS
ESBYG
ESX
EX3
F5P
FEDTE
FERAY
FFXSO
FIGPU
FNLPD
FRRFC
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GXS
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IAO
ICJ
IHE
IHR
IJ-
IKXTQ
IMOTQ
INH
INR
IPY
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KPH
LAS
LLZTM
M4Y
MA-
MK0
N9A
NB0
NPVJJ
NQJWS
NU0
O93
O9G
O9I
O9J
OAM
P19
P2P
PF-
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R89
R9I
RIG
ROL
RPX
RRX
RSV
S16
S27
S3A
S3B
SAP
SBL
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SPISZ
SRMVM
SSLCW
SSXJD
SV3
SZN
T13
TN5
TSG
TSK
TSV
TUC
TUS
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
VC2
W23
W48
WH7
WIP
WJK
WK8
WOW
YLTOR
Z45
Z7U
Z7W
Z82
Z83
Z87
Z8O
Z8Q
Z8V
Z8W
Z91
ZMTXR
ZOVNA
~8M
5PM
ID FETCH-LOGICAL-c408t-665f8722a379ebef2f8721b2d3384343ac5c6f141879e127de6c9a40f8e8d90d3
IEDL.DBID 7X7
ISSN 0033-3158
IngestDate Wed Dec 27 05:21:39 EST 2023
Sat Oct 26 01:23:02 EDT 2024
Thu Oct 10 15:56:31 EDT 2024
Fri Aug 23 01:56:21 EDT 2024
Wed Oct 12 11:22:09 EDT 2022
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Self-administration
Mice
Ethanol
Serotonin
5-HT
Ayahuasca
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c408t-665f8722a379ebef2f8721b2d3384343ac5c6f141879e127de6c9a40f8e8d90d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-4841-4117
PMID 35253069
PQID 2672839997
PQPubID 47309
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_10750423
proquest_miscellaneous_2636869404
proquest_journals_2672839997
crossref_primary_10_1007_s00213_022_06104_w
springer_journals_10_1007_s00213_022_06104_w
PublicationCentury 2000
PublicationDate 2022-06-01
PublicationDateYYYYMMDD 2022-06-01
PublicationDate_xml – month: 06
  year: 2022
  text: 2022-06-01
  day: 01
PublicationDecade 2020
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Heidelberg
PublicationTitle Psychopharmacology
PublicationTitleAbbrev Psychopharmacology
PublicationYear 2022
Publisher Springer Berlin Heidelberg
Springer Nature B.V
Publisher_xml – name: Springer Berlin Heidelberg
– name: Springer Nature B.V
References Grant, Goldstein, Saha, Chou, Jung, Zhang, Pickering, Ruan, Smith, Huang, Hasin (CR12) 2015; 72
Nolli, de Oliveira, Alves, von Zuben, Pic-Taylor, Mortari, Caldas (CR21) 2020; 84
Argento, Capler, Thomas, Lucas, Tupper (CR1) 2019; 38
Reis, Rodrigues, Anjos-Santos, Libarino-Santos, Serra, Cata-Preta, Oliveira-Campos, Kisaki, Barros-Santos, Yokoyama, Cruz, Oliveira-Lima, Barbosa, Berro, Marinho (CR24) 2020; 237
Maurel, De Vry, Schreiber (CR18) 1999; 370
Berquist, Fantegrossi (CR4) 2021; 32
Maisel, Blodgett, Wilbourne, Humphreys, Finney (CR17) 2013; 108
Bogenschutz, Forcehimes, Pommy, Wilcox, Barbosa, Strassman (CR6) 2015; 29
Cunningham, Anastasio, Fox, Stutz, Bubar, Swinford, Watson, Gilbertson, Rice, Rosenzweig-Lipson, Moeller (CR9) 2013; 4
Barbosa, Tófoli, Bogenschutz, Hoy, Berro, Marinho, Areco, Winkelman (CR3) 2018; 9
Howell, Cunningham (CR14) 2015; 67
Bogenschutz (CR5) 2013; 6
Witkiewitz, Litten, Leggio (CR27) 2019; 5
Loizaga-Velder, Verres (CR16) 2014; 46
CR28
McKenna (CR19) 2004; 102
Thomas, Lucas, Capler, Tupper, Martin (CR25) 2013; 6
CR23
CR22
Glennon, Dukat, Grella, Hong, Costantino, Teitler, Smith, Egan, Davis, Mattson (CR11) 2000; 60
Ding, Toalston, Oster, McBride, Rodd (CR10) 2009; 204
Hamill, Hallak, Dursun, Baker (CR13) 2019; 17
Cata-Preta, Serra, Moreira-Junior, Reis, Kisaki, Libarino-Santos, Silva, Barros-Santos, Santos, Barbosa, Costa, Oliveira-Lima, Berro, Marinho (CR8) 2018; 9
Li, Cheng, Bian, Liu, Zhang, Ye (CR15) 2010; 34
Valyear, Villaruel, Chaudhri (CR26) 2017; 141
Brodie, Trifunovic, Shefner (CR7) 1995; 273
Barbosa, Strassman, da Silveira, Areco, Hoy, Pommy, Thoma, Bogenschutz (CR2) 2016; 71
NicDhonnchadha, Fox, Stutz, Rice, Cunningham (CR20) 2009; 123
ZM Ding (6104_CR10) 2009; 204
MD Berquist (6104_CR4) 2021; 32
G Thomas (6104_CR25) 2013; 6
K Witkiewitz (6104_CR27) 2019; 5
BA NicDhonnchadha (6104_CR20) 2009; 123
J Li (6104_CR15) 2010; 34
NC Maisel (6104_CR17) 2013; 108
MP Bogenschutz (6104_CR6) 2015; 29
A Loizaga-Velder (6104_CR16) 2014; 46
MP Bogenschutz (6104_CR5) 2013; 6
LM Nolli (6104_CR21) 2020; 84
PCR Barbosa (6104_CR3) 2018; 9
KA Cunningham (6104_CR9) 2013; 4
LL Howell (6104_CR14) 2015; 67
BF Grant (6104_CR12) 2015; 72
E Argento (6104_CR1) 2019; 38
RA Glennon (6104_CR11) 2000; 60
6104_CR22
PC Barbosa (6104_CR2) 2016; 71
DJ McKenna (6104_CR19) 2004; 102
S Maurel (6104_CR18) 1999; 370
HS Reis (6104_CR24) 2020; 237
MS Brodie (6104_CR7) 1995; 273
EG Cata-Preta (6104_CR8) 2018; 9
MD Valyear (6104_CR26) 2017; 141
6104_CR23
J Hamill (6104_CR13) 2019; 17
6104_CR28
References_xml – ident: CR22
– volume: 29
  start-page: 289
  issue: 3
  year: 2015
  end-page: 299
  ident: CR6
  article-title: Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study
  publication-title: J Psychopharmacol
  doi: 10.1177/0269881114565144
  contributor:
    fullname: Strassman
– volume: 273
  start-page: 1139
  year: 1995
  end-page: 1146
  ident: CR7
  article-title: Serotonin potentiates ethanol-induced excitation of ventral tegmental area neurons in brain slices from three different rat strains
  publication-title: J Pharmacol Exp Ther
  contributor:
    fullname: Shefner
– volume: 67
  start-page: 176
  issue: 1
  year: 2015
  end-page: 197
  ident: CR14
  article-title: Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder
  publication-title: Pharmacol Rev
  doi: 10.1124/pr.114.009514
  contributor:
    fullname: Cunningham
– volume: 32
  start-page: 382
  issue: 5
  year: 2021
  end-page: 391
  ident: CR4
  article-title: Effects of 5-HT2A receptor agonist 2,5-dimethoxy-4-iodoamphetamine on alcohol consumption in Long-Evans rats
  publication-title: Behav Pharmacol
  doi: 10.1097/FBP.0000000000000628
  contributor:
    fullname: Fantegrossi
– volume: 370
  start-page: 217
  issue: 3
  year: 1999
  end-page: 223
  ident: CR18
  article-title: 5-HT receptor ligands differentially affect operant oral self-administration of ethanol in the rat
  publication-title: Eur J Pharmacol
  doi: 10.1016/S0014-2999(99)00125-9
  contributor:
    fullname: Schreiber
– volume: 204
  start-page: 381
  issue: 3
  year: 2009
  end-page: 390
  ident: CR10
  article-title: Involvement of local serotonin-2A but not serotonin-1B receptors in the reinforcing effects of ethanol within the posterior ventral tegmental area of female Wistar rats
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-009-1468-9
  contributor:
    fullname: Rodd
– volume: 6
  start-page: 30
  issue: 1
  year: 2013
  end-page: 42
  ident: CR25
  article-title: Ayahuasca-assisted therapy for addiction: results from a preliminary observational study in Canada
  publication-title: Curr Drug Abuse Rev
  doi: 10.2174/15733998113099990003
  contributor:
    fullname: Martin
– volume: 71
  start-page: 95
  year: 2016
  end-page: 105
  ident: CR2
  article-title: Psychological and neuropsychological assessment of regular hoasca users
  publication-title: Compr Psychiatry
  doi: 10.1016/j.comppsych.2016.09.003
  contributor:
    fullname: Bogenschutz
– volume: 9
  start-page: 561
  year: 2018
  ident: CR8
  article-title: Ayahuasca and its DMT- and beta-carbolines - containing ingredients block the expression of ethanol-induced conditioned place preference in mice: role of the treatment environment
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2018.00561
  contributor:
    fullname: Marinho
– ident: CR23
– volume: 6
  start-page: 17
  issue: 1
  year: 2013
  end-page: 29
  ident: CR5
  article-title: Studying the effects of classic hallucinogens in the treatment of alcoholism: Rationale, methodology, and current research with psilocybin
  publication-title: Curr Drug Abuse Rev
  doi: 10.2174/15733998113099990002
  contributor:
    fullname: Bogenschutz
– volume: 5
  start-page: 4043
  issue: 9
  year: 2019
  ident: CR27
  article-title: Advances in the science and treatment of alcohol use disorder
  publication-title: Sci Adv
  doi: 10.1126/sciadv.aax4043
  contributor:
    fullname: Leggio
– volume: 60
  start-page: 121
  issue: 2
  year: 2000
  end-page: 132
  ident: CR11
  article-title: Binding of beta-carbolines and related agents at serotonin (5-HT(2) and 5-HT(1A)), dopamine (D(2)) and benzodiazepine receptors
  publication-title: Drug Alcohol Depend
  doi: 10.1016/S0376-8716(99)00148-9
  contributor:
    fullname: Mattson
– volume: 102
  start-page: 111
  issue: 2
  year: 2004
  end-page: 129
  ident: CR19
  article-title: Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges
  publication-title: Pharmacol Ther
  doi: 10.1016/j.pharmthera.2004.03.002
  contributor:
    fullname: McKenna
– volume: 72
  start-page: 757
  issue: 8
  year: 2015
  end-page: 766
  ident: CR12
  article-title: Epidemiology of DSM-5 alcohol use disorder: results from the national epidemiologic survey on alcohol and related conditions III
  publication-title: JAMA Psychiat
  doi: 10.1001/jamapsychiatry.2015.0584
  contributor:
    fullname: Hasin
– volume: 84
  start-page: 67
  year: 2020
  end-page: 75
  ident: CR21
  article-title: Effects of the hallucinogenic beverage ayahuasca on voluntary ethanol intake by rats and on cFos expression in brain areas relevant to drug addiction
  publication-title: Alcohol
  doi: 10.1016/j.alcohol.2019.10.005
  contributor:
    fullname: Caldas
– volume: 9
  start-page: 136
  year: 2018
  ident: CR3
  article-title: Assessment of alcohol and tobacco use disorders among religious users of ayahuasca
  publication-title: Front Psychiatry
  doi: 10.3389/fpsyt.2018.00136
  contributor:
    fullname: Winkelman
– volume: 17
  start-page: 108
  issue: 2
  year: 2019
  end-page: 128
  ident: CR13
  article-title: Ayahuasca: psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness
  publication-title: Curr Neuropharmacol
  doi: 10.2174/1570159X16666180125095902
  contributor:
    fullname: Baker
– volume: 46
  start-page: 63
  issue: 1
  year: 2014
  end-page: 72
  ident: CR16
  article-title: Therapeutic effects of ritual ayahuasca use in the treatment of substance dependence–qualitative results
  publication-title: J Psychoactive Drugs
  doi: 10.1080/02791072.2013.873157
  contributor:
    fullname: Verres
– volume: 38
  start-page: 781
  issue: 7
  year: 2019
  end-page: 789
  ident: CR1
  article-title: Exploring ayahuasca-assisted therapy for addiction: a qualitative analysis of preliminary findings among an Indigenous community in Canada
  publication-title: Drug Alcohol Rev
  doi: 10.1111/dar.12985
  contributor:
    fullname: Tupper
– volume: 237
  start-page: 3269
  issue: 11
  year: 2020
  end-page: 3281
  ident: CR24
  article-title: Ayahuasca blocks the reinstatement of methylphenidate-induced conditioned place preference in mice: behavioral and brain Fos expression evaluations
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-020-05609-6
  contributor:
    fullname: Marinho
– volume: 34
  start-page: 1742
  issue: 10
  year: 2010
  end-page: 1750
  ident: CR15
  article-title: Region-specific induction of FosB/deltaFosB by voluntary alcohol intake: effects of naltrexone
  publication-title: Alcohol Clin Exp Res
  doi: 10.1111/j.1530-0277.2010.01261.x
  contributor:
    fullname: Ye
– volume: 4
  start-page: 110
  issue: 1
  year: 2013
  end-page: 121
  ident: CR9
  article-title: Synergism between a serotonin 5-HT2A receptor (5-HT2AR) antagonist and 5-HT2CR agonist suggests new pharmacotherapeutics for cocaine addiction
  publication-title: ACS Chem Neurosci
  doi: 10.1021/cn300072u
  contributor:
    fullname: Moeller
– volume: 141
  start-page: 26
  issue: Pt 1
  year: 2017
  end-page: 32
  ident: CR26
  article-title: Alcohol-seeking and relapse: a focus on incentive salience and contextual conditioning
  publication-title: Behav Processes
  doi: 10.1016/j.beproc.2017.04.019
  contributor:
    fullname: Chaudhri
– ident: CR28
– volume: 108
  start-page: 275
  issue: 2
  year: 2013
  end-page: 293
  ident: CR17
  article-title: Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2012.04054.x
  contributor:
    fullname: Finney
– volume: 123
  start-page: 382
  issue: 2
  year: 2009
  end-page: 396
  ident: CR20
  article-title: Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model
  publication-title: Behav Neurosci
  doi: 10.1037/a0014592
  contributor:
    fullname: Cunningham
– volume: 60
  start-page: 121
  issue: 2
  year: 2000
  ident: 6104_CR11
  publication-title: Drug Alcohol Depend
  doi: 10.1016/S0376-8716(99)00148-9
  contributor:
    fullname: RA Glennon
– volume: 102
  start-page: 111
  issue: 2
  year: 2004
  ident: 6104_CR19
  publication-title: Pharmacol Ther
  doi: 10.1016/j.pharmthera.2004.03.002
  contributor:
    fullname: DJ McKenna
– volume: 6
  start-page: 30
  issue: 1
  year: 2013
  ident: 6104_CR25
  publication-title: Curr Drug Abuse Rev
  doi: 10.2174/15733998113099990003
  contributor:
    fullname: G Thomas
– volume: 9
  start-page: 136
  year: 2018
  ident: 6104_CR3
  publication-title: Front Psychiatry
  doi: 10.3389/fpsyt.2018.00136
  contributor:
    fullname: PCR Barbosa
– volume: 32
  start-page: 382
  issue: 5
  year: 2021
  ident: 6104_CR4
  publication-title: Behav Pharmacol
  doi: 10.1097/FBP.0000000000000628
  contributor:
    fullname: MD Berquist
– volume: 34
  start-page: 1742
  issue: 10
  year: 2010
  ident: 6104_CR15
  publication-title: Alcohol Clin Exp Res
  doi: 10.1111/j.1530-0277.2010.01261.x
  contributor:
    fullname: J Li
– volume: 46
  start-page: 63
  issue: 1
  year: 2014
  ident: 6104_CR16
  publication-title: J Psychoactive Drugs
  doi: 10.1080/02791072.2013.873157
  contributor:
    fullname: A Loizaga-Velder
– volume: 9
  start-page: 561
  year: 2018
  ident: 6104_CR8
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2018.00561
  contributor:
    fullname: EG Cata-Preta
– volume: 273
  start-page: 1139
  year: 1995
  ident: 6104_CR7
  publication-title: J Pharmacol Exp Ther
  contributor:
    fullname: MS Brodie
– volume: 141
  start-page: 26
  issue: Pt 1
  year: 2017
  ident: 6104_CR26
  publication-title: Behav Processes
  doi: 10.1016/j.beproc.2017.04.019
  contributor:
    fullname: MD Valyear
– volume: 6
  start-page: 17
  issue: 1
  year: 2013
  ident: 6104_CR5
  publication-title: Curr Drug Abuse Rev
  doi: 10.2174/15733998113099990002
  contributor:
    fullname: MP Bogenschutz
– volume: 38
  start-page: 781
  issue: 7
  year: 2019
  ident: 6104_CR1
  publication-title: Drug Alcohol Rev
  doi: 10.1111/dar.12985
  contributor:
    fullname: E Argento
– ident: 6104_CR23
  doi: 10.1111/dar.13348
– volume: 29
  start-page: 289
  issue: 3
  year: 2015
  ident: 6104_CR6
  publication-title: J Psychopharmacol
  doi: 10.1177/0269881114565144
  contributor:
    fullname: MP Bogenschutz
– volume: 237
  start-page: 3269
  issue: 11
  year: 2020
  ident: 6104_CR24
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-020-05609-6
  contributor:
    fullname: HS Reis
– volume: 370
  start-page: 217
  issue: 3
  year: 1999
  ident: 6104_CR18
  publication-title: Eur J Pharmacol
  doi: 10.1016/S0014-2999(99)00125-9
  contributor:
    fullname: S Maurel
– volume: 67
  start-page: 176
  issue: 1
  year: 2015
  ident: 6104_CR14
  publication-title: Pharmacol Rev
  doi: 10.1124/pr.114.009514
  contributor:
    fullname: LL Howell
– volume: 71
  start-page: 95
  year: 2016
  ident: 6104_CR2
  publication-title: Compr Psychiatry
  doi: 10.1016/j.comppsych.2016.09.003
  contributor:
    fullname: PC Barbosa
– volume: 108
  start-page: 275
  issue: 2
  year: 2013
  ident: 6104_CR17
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2012.04054.x
  contributor:
    fullname: NC Maisel
– volume: 123
  start-page: 382
  issue: 2
  year: 2009
  ident: 6104_CR20
  publication-title: Behav Neurosci
  doi: 10.1037/a0014592
  contributor:
    fullname: BA NicDhonnchadha
– ident: 6104_CR28
– volume: 4
  start-page: 110
  issue: 1
  year: 2013
  ident: 6104_CR9
  publication-title: ACS Chem Neurosci
  doi: 10.1021/cn300072u
  contributor:
    fullname: KA Cunningham
– volume: 204
  start-page: 381
  issue: 3
  year: 2009
  ident: 6104_CR10
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-009-1468-9
  contributor:
    fullname: ZM Ding
– volume: 5
  start-page: 4043
  issue: 9
  year: 2019
  ident: 6104_CR27
  publication-title: Sci Adv
  doi: 10.1126/sciadv.aax4043
  contributor:
    fullname: K Witkiewitz
– volume: 84
  start-page: 67
  year: 2020
  ident: 6104_CR21
  publication-title: Alcohol
  doi: 10.1016/j.alcohol.2019.10.005
  contributor:
    fullname: LM Nolli
– ident: 6104_CR22
  doi: 10.1016/j.physbeh.2015.01.032
– volume: 72
  start-page: 757
  issue: 8
  year: 2015
  ident: 6104_CR12
  publication-title: JAMA Psychiat
  doi: 10.1001/jamapsychiatry.2015.0584
  contributor:
    fullname: BF Grant
– volume: 17
  start-page: 108
  issue: 2
  year: 2019
  ident: 6104_CR13
  publication-title: Curr Neuropharmacol
  doi: 10.2174/1570159X16666180125095902
  contributor:
    fullname: J Hamill
SSID ssj0000484
ssj0068394
Score 2.5038846
Snippet Rationale Ayahuasca has been proposed as a potential treatment of alcohol (ethanol) use disorder (AUD). The serotonin 5-HT 2A receptor agonist...
Abstract RationaleAyahuasca has been proposed as a potential treatment of alcohol (ethanol) use disorder (AUD). The serotonin 5-HT2A receptor agonist...
RATIONALEAyahuasca has been proposed as a potential treatment of alcohol (ethanol) use disorder (AUD). The serotonin 5-HT2A receptor agonist...
SourceID pubmedcentral
proquest
crossref
springer
SourceType Open Access Repository
Aggregation Database
Publisher
StartPage 1679
SubjectTerms Agonists
Alcohol
Biomedical and Life Sciences
Biomedicine
Drinking behavior
Drug self-administration
Ethanol
Neurosciences
Original Investigation
Pharmacology/Toxicology
Psychedelic drugs
Psychiatry
Psychotropic drugs
Receptor mechanisms
Serotonin S2 receptors
SummonAdditionalLinks – databaseName: SpringerLINK - Czech Republic Consortium
  dbid: AGYKE
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Nb9QwEB1BKyEufBQQgYIGCfXCukocx3GOK9SyAhVVaCuVU2QnTrtiN6nYrFbLlT-OJx8bbYFDj0ksO5HH4-fMvDcA74PE8lhby3JpNBMiFCyxJmOmMCqJtUPYjeLN2Vc5uRCfL6PLgcfdJLv3EcnGUW-5brQbUciRUzECX7D1fdjviKf740_fv5wMDlgQ97K9kA4AtErMIfHIItURZ_7d5e7mNCDO2_mSt4KmzV50-himPaOnTUH5cbyqzXH262-Bx7t85hN41GFTHLfG9BTu2fIAHpx10fcDODpvda43I5wOtK3lCI_wfFDA3jyD39-qucWqwIhNpnyMzqvaGyrrg7MSHeLELouEmuiNvl7pZaaxKtHSj_xqjks7L5je0fVFytC_Qo31umJU_8yN4Fy383NI8uX57GpBvS_chocLd_c5XJyeTD9OWFftgWXCVzWTMipUzLkOY2cttuB0FRieu0M00V91FmWyCASVR7cBj3Mrs0QLv1BW5Ymfhy9gr6xK-xIwVDbQsTTuyK1FYJyPsibPQx4ZHQrl5x586Kc5vWlFPdKtfHMzAambgLSZgHTtwWFvCWm3wJcpl7EDZg5dxx682z52S5PiLbq01YrahFLJRPjCA7VjQdtRSdx790k5u25EvgPCcg7rejDqDWUY_f8v--puzV_DQ97aGvODQ9irf67sG4eyavO2W1V_ABz0Hs0
  priority: 102
  providerName: Springer Nature
Title Role of 5-HT2A receptors in the effects of ayahuasca on ethanol self-administration using a two-bottle choice paradigm in male mice
URI https://link.springer.com/article/10.1007/s00213-022-06104-w
https://www.proquest.com/docview/2672839997
https://search.proquest.com/docview/2636869404
https://pubmed.ncbi.nlm.nih.gov/PMC10750423
Volume 239
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Ra9swEBZbC2MvY-s2lq0rGoy-LGK2LEv200hGsrDREEoC2ZORLLkNJHY2J4Q874_vznZiUtiejCzZEtzp7qS7-46Qj37suNLOMSuNZkIEgsXOpMxkJoqVBgu7Qry5GcvRTHyfh_Pmwq1swioPMrES1LZI8Y78M5cKNCGYM-rL-hfDqlHoXW1KaDwm5z73JIZ0qblqJbHAJMy6IeHjGpI5wISyMGoyaKo8OtR06M7kWOjAE2x3qqVa0_Nh4OQD72mllIbPybPGmqS9mvwvyCOXX5AnN42__IJcT2pk6n2XTttEq7JLr-mkxazevyR_boulo0VGQzaa8h4FOejWWIiHLnIKNiJt4j5wiN7r-60uU02LnDq8ei-WtHTLjOkTJF6KMfV3VNPNrmBYsQxmAGELkoki4Lhd3K3w7ytQUXQFb1-R2XAw_TpiTX0Glgov2jApwyxSnOtAAX1dxrHlG27h2IsJqzoNU5n5AguaO58r62Qaa-FlkYts7NngNTnLi9y9ITSInK-VNHBI1sI3IFWcsTbgodGBiDzbIZ8O9EjWNQxHcgRcrqiXAPWSinrJrkMuDyRLmi1ZJi0DdciHYzdsJvSQ6NwVWxwTyEjGwhMdEp2Q-jgrwnGf9uSL-wqW20frC6zTDukeuKKd_d-Lffv_xb4jT3nNmMzzL8nZ5vfWvQc7aGOuKma_Iue9Yb8_xue3nz8G8OwPxpNb6J3x3l818AsC
link.rule.ids 230,315,783,787,888,12068,21400,27936,27937,31731,31732,33756,33757,41093,41535,42162,42604,43322,43817,52123,52246,74073,74630
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Rb9MwED7BkIAXBAO0jAFGQnuhFonj2M4TmhBTgXWaUCf1LbJjZ6vUJmVpVfWZP44vSRt1EjwmdmJLZ9999t19B_AxSh2T2jlqhdGU85jT1JmcmsKoVGqPsBvGm9GlGF7zH5Nk0l241V1Y5VYnNoraVjnekX9mQnpL6OGM_LL4TbFqFHpXuxIaD-ER8nBhBQM5kb0m5piE2T4I_3FLyRxjQlmiugyaJo8OLR26MxkWOgg5Xe9bqR563g-cvOc9bYzS-XN41qFJctaK_wU8cOUhPB51_vJDOL1qmak3AzLuE63qATklVz1n9eYl_PlVzRypCpLQ4ZidEa8H3QIL8ZBpSTxGJF3cB3bRG3270nWuSVUSh1fv1YzUblZQvcfESzCm_oZoslxXFCuW-RG8svWaiSDhuJ3ezPHvc2-iyNy_fQXX59_GX4e0q89Acx6qJRUiKZRkTMfSy9cVDJ8iw6w_9mLCqs6TXBQRx4LmLmLSOpGnmoeFcsqmoY1fw0FZle4ISKxcpKUw_pCseWS8VnHG2pglRsdchTaAT1t5ZIuWhiPbES430su89LJGetk6gJOtyLJuS9ZZv4AC-LBr9psJPSS6dNUK-8RCiZSHPAC1J-rdqEjHvd9STm8bWu4I0ZdHpwEMtquiH_3fkz3-_2Tfw5PheHSRXXy__PkGnrJ2kdIwOoGD5d3KvfWYaGneNQv_L5rCCFY
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fa9swED62FMpeRtdtzFu3aTD6sojasizLT6PbGrIfDaGk0DcjW3IbSOysTgh53j8-na3EpLA9yhaS4U53n3x33wF8DBLDYmUM1SJTlPOQ08RkOc2KTCaxsgi7Yby5HInhNf9xE924_KfapVVubWJjqHWV4z_yMyZi6wktnInPCpcWMf42-Lz4TbGDFEZaXTuNx3AQcxH6PTj4cjEaX3V2mWNJZjsQdqmWoDnE8rJIunqapqoO_R4GNxm2PfA5Xe_7rA6IPkyjfBBLbVzU4AieOmxJzltleAaPTHkMh5cuen4Mp-OWp3rTJ5Ou7Kruk1My7hisN8_hz1U1M6QqSESHE3ZOrFU0C2zLQ6YlsYiRuCwQnKI26m6l6lyRqiQGf8RXM1KbWUHVHi8vwQz7W6LIcl1R7F9md7Cm19opgvTjeno7x9Xn1mGRuX36Aq4HF5OvQ-q6NdCc-3JJhYgKGTOmwthK2xQMR0HGtL0EY_mqyqNcFAHH9uYmYLE2Ik8U9wtppE58Hb6EXlmV5hWQUJpAxSKzV2bFg8zaGJNpHbIoUyGXvvbg01Ye6aIl5Uh39MuN9FIrvbSRXrr24GQrstQd0Drt1MmDD7vX9mhhvESVplrhnFBIkXCfeyD3RL3bFcm599-U07uGpDtALGaxqgf9rVZ0u__7Y1___2Pfw6HV-vTX99HPN_CEtTpK_eAEesv7lXlrAdIye-c0_y-rtw3z
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Role+of+5-HT2A+receptors+in+the+effects+of+ayahuasca+on+ethanol+self-administration+using+a+two-bottle+choice+paradigm+in+male+mice&rft.jtitle=Psychopharmacology&rft.au=Serra%2C+Yasmim+A.&rft.au=Barros-Santos%2C+Tha%C3%ADsa&rft.au=Anjos-Santos%2C+Alexia&rft.au=Kisaki%2C+Natali+D.&rft.date=2022-06-01&rft.issn=0033-3158&rft.eissn=1432-2072&rft.volume=239&rft.issue=6&rft.spage=1679&rft.epage=1687&rft_id=info:doi/10.1007%2Fs00213-022-06104-w&rft_id=info%3Apmid%2F35253069&rft.externalDBID=PMC10750423
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0033-3158&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0033-3158&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0033-3158&client=summon